Amerikanische Gesellschaft für Hirudotherapie

Susruta (Suśruta)

c. 600 BCE · Inder (Antike) · Chirurgie

Biografische ReferenzHistorischer Eintrag
AntikeChirurgie

Antiker indischer Chirurg, dem traditionell die Autorschaft der Sushruta Samhita zugeschrieben wird, die die älteste erhaltene systematische Abhandlung über die Anwendung medizinischer Blutegel innerhalb eines chirurgischen Textes enthält.

Profil

Lebensjahre
c. 600 BCE
Nationalität
Indian (Ancient)
Epoche
Antike
Hauptfachgebiet
Chirurgie

Institutionelle Zugehörigkeiten

  • Ancient Indian medical tradition (Ayurveda) — exact institutional affiliation unknown

Wichtige Beiträge

  • Traditionally credited as the principal author of the Sushruta Samhita, one of the foundational Sanskrit texts of Ayurvedic medicine and surgery.
  • The Sushruta Samhita contains a dedicated chapter (Jalaukāvacāraṇīya, Sutrasthana 13) on the application of leeches (Sanskrit jalauka), describing indications, leech selection, application technique, and post-application care.
  • Distinguished therapeutic (non-venomous) leech species from venomous freshwater leeches, an early taxonomic discrimination relevant to modern medicinal-leech species selection.
  • Described leech application as the gentlest of the bloodletting methods, suitable for delicate patients, children, and the elderly when venesection was considered too aggressive.
  • His surgical text integrates leech therapy into a broader system that includes plastic and reconstructive procedures for nasal and ear reconstruction, anticipating themes that resurface in modern reconstructive microsurgery contexts where leeches are FDA-cleared.

Bedeutung für die Hirudotherapie

Susruta occupies the foundational position in the Indian textual tradition of medicinal leech application. The Sushruta Samhita, whose extant form is generally dated by scholars to the early centuries of the common era but whose core material is traditionally ascribed to a much earlier teaching lineage, contains the earliest known systematic surgical and procedural discussion of leech therapy in any medical literature. The dedicated chapter on leech application within the Sutrasthana describes the procedure in remarkable practical detail: how to identify suitable therapeutic species, how to keep leeches before use, how to encourage attachment to the patient, how to detach leeches once feeding is complete, and how to manage the patient and the leech afterwards. The Indian tradition's classification of leeches into categories of suitability for medical use — distinguishing therapeutic leeches from those whose bite was considered harmful — represents one of the earliest exercises in what would today be called medical-grade species selection. The same conceptual move would be made again, with modern molecular taxonomy, in the twenty-first century when Siddall and colleagues clarified that the commercial medicinal leech of European pharmacies was largely Hirudo verbana rather than Hirudo medicinalis sensu stricto. The American Society of Hirudotherapy regards the Sushruta tradition as one of the great independent ancient sources of medicinal-leech doctrine, parallel to and largely independent of the Greco-Roman lineage that runs from Hippocrates through Galen and Avicenna. The persistence of jalauka therapy within classical Ayurveda — and its formal recognition by the Government of India's Ministry of AYUSH as a regulated traditional medical procedure — represents a continuous practice tradition extending across more than two thousand years.

Wichtige Publikationen

  1. Sushruta Samhita (Suśrutasaṃhitā) · Sanskrit surgical compendium, transmitted via manuscript tradition (-600)

Externe Ressourcen

Beeinflusste Forschung

Verbindungen und Forschungsbereiche, die auf die Beiträge dieser Persönlichkeit zurückgehen:

Verwandte Persönlichkeiten

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Freigabe für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.